Glucocorticoid-induced osteoporosis

Cleveland Clinic Journal of Medicine

Volumn 77, Issue 12, 2010, Pages 843-843

  Thacker, Holly ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

CHEMICALLY INDUCED DISORDER; FEMALE; HORMONE SUBSTITUTION; HUMAN; LETTER; MALE; OSTEOPOROSIS; RISK FACTOR; WOMEN'S HEALTH;

FEMALE; GLUCOCORTICOIDS; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; OSTEOPOROSIS; RISK FACTORS; WOMEN'S HEALTH;

EID: 78650339762     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.77c.12001     Document Type: Letter

References (5)

1. Dore RK. How to prevent glucocorticoid-induced osteoporosis. Cleve Clin J Med 2010; 77:529-536.
2. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in ealthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002; 288:321-333.
3. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010. www.menopause.org. Accessed October 28, 2010.
4. American Association of Clinical Endocrinologists. Position statement on hormone replacement therapy and cardiovascular risk. www.aace.com/pub/pdf/guidelines/HRTCVRISKposition_statement.pdf. Accessed October 28, 2010.
5. Compston JE. The risks and benefits of HRT. J Musculoskelet Neuronal Interact 2004; 4:187-190.